Company profile
Akebia Therapeutics, Inc. Insider Trading
AKBAEvery SEC Form 4 insider trading filing for Akebia Therapeutics, Inc. (AKBA) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001517022
- Filings
- 80
- Insiders
- 18
- Last filing
- 2026-08-06
Activity summary
No insider transactions in the last 30 days. The most recent was on August 6, 2026, when John P. Butler bought 350,000 shares. 80 filings from 18 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Akebia Therapeutics, Inc. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $901K.
90 day insight
Over the last 90 days, Akebia Therapeutics, Inc. insiders bought $221K across 2 transactions with no open-market sales.
- Most active insider: John P. Butler with 2 transactions totaling $221K.
- Largest single purchase: $221K by John P. Butler on Aug 6, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades, typically less informative than open-market activity.
Activity skews bullish: buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | John P. Butler | AKBA | Option Exercise | 350,000 | $0.63 | $221K |
| Aug 6, 2026 | John P. Butler | AKBA | Option Exercise | 350,000 | — | — |
| Jun 29, 2026 | Erik Ostrowski | AKBA | Sale10b5 | 56,019 | $1.11 | $62K |
| Jun 17, 2026 | Adrian Adams | AKBA | Award | 35,700 | — | — |
| Jun 17, 2026 | Adrian Adams | AKBA | Award | 53,600 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=AKBA" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Akebia Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →